Vermont Pharmacy CE Requirement 20-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Monitoring Techniques for Optimal Diabetes Management and Control 2Course release date: 10/12/2022
About this Course
The purpose of this course is to assist in the successful management of diabetes, including blood glucose monitoring (BGM) and the ability of persons with diabetes to monitor the effectiveness of their diabetes treatment plan to understand better the interrelationships of food, activity, and medication-taking. In addition, BGM data can alert the person to hypoglycemia and hyperglycemia, inspiring lifestyle modifications that may help people with diabetes achieve their A1C goals. Diabetes technology has resulted in many improvements in blood glucose meters. Continuing advances in BGM have led to the development of continuous glucose monitoring (CGM) systems that enable people with diabetes to optimize glycemic stability and improve the quality of their lives. This course reviews the features and functionality of BGM with glucometers and CGMs in line with the 2022 American Diabetes Association (ADA) evidence-based guidelines integrated into clinical practice.
- Prescribing Controlled Substances Safely: A DEA Requirement 8
Course release date: 5/1/2023
About the Course
Nurse Practitioners (NPs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- The Essentials of Infection Prevention 4
Course release date: 7/10/2023
About the Course
The COVID-19 pandemic made all healthcare workers acutely aware of infection prevention and control measures. The pandemic has highlighted the need for ongoing education to maintain a knowledge and skill level appropriate for implementing strategies to prevent healthcare-associated infections and to prepare for the next pandemic. Understanding where reservoirs are harboring pathogens and strategies to prevent transmission in healthcare settings is critical. This course will examine best practices for infection prevention, such as hand hygiene, personal protective equipment, transmission-based precautions, cleaning and disinfection, and injection safety
- The Pharmacist's Role in the Opioid Crisis, 2nd Edition 6
Course Release: 1/9/2024
About the course
This course will provide pharmacists practicing in healthcare systems and community pharmacy settings an overview of contemporary considerations for ways that the opioid crisis intersects with pharmacy practice. This course will provide pharmacists with a history of the current state of the opioid crisis and how pharmacy practice has expanded to meet patient and community needs as well as ethical dimensions of the opioid crisis and the role of social determinants of health in opioid-related disparities. This course will provide pharmacists with an understanding of the disease state of opioid use disorder and how opioids affect the brain, how the pharmacist can be supportive of patients with opioid use disorder to reduce stigma and facilitate treatment-seeking, and the benefits of medications for opioid use disorder; participants will review the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022 Clinical Practice Guideline).